Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis

Cancer Genetics and Cytogenetics

Volumn 160, Issue 2, 2005, Pages 164-168

  Güran, Şefik ^a   Özet, Ahmet ^b   Dede, Murat ^b   Gille, Johan J P ^c   Yenen, Müfit Cemal ^b  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Department of Oncology BD ^*  (Turkey)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; CYSTADENOMA; DNA DETERMINATION; FAMILIAL CANCER; FAMILY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; GERM LINE; HEREDITARY BREAST OVARY CANCER SYNDROME; HUMAN; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; ONCOGENE; PRIORITY JOURNAL; TURKEY (BIRD);

BREAST NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENES, BRCA1; GENES, BRCA2; GERM-LINE MUTATION; HUMANS; INTRONS; MALE; NEOPLASTIC SYNDROMES, HEREDITARY; OVARIAN NEOPLASMS; PEDIGREE; TUMOR SUPPRESSOR PROTEIN P53; TURKEY;

EID: 21344437932     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2005.01.001     Document Type: Article

References (27)

1. J.R. Harris, M. Morrow, and G. Bonadonna Cancer of the breast V.T. De Vita S. Hellman S.A. Rosenberg Cancer: principles and practice of oncology 4th ed. 1993 Lippincott Philadelphia 1264 1332
2. P.A. Pizzo, and D.G. Poplack Principles and practice of pediatric oncology 2nd ed. 1993 Lippincott Philadelphia
3. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular cloning. a laboratory manual 2nd edition 1989 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY
4. Breast Cancer Information Core (BIC) database. An open access on-line breast cancer mutation data base. Available at: http://research.nhgri.nih.gov/ bic/.
5. S. Güran, and M. Safali A case of neurofibromatosis and breast cancer: loss of heterozygosity of NF1 in breast cancer Cancer Genet Cytogenet 156 2005 86 88
6. INK4A mutations during the progression of glomus tumor Pathol Oncol Res 5 1999 41 45
7. V.L. Buchman, P.M. Chumakov, N.N. Ninkina, O.P. Samarina, and G.P. Georgiev A variation in the structure of the protein-coding region of human p53 gene Gene 70 1988 245 252
8. J.J. Gille, F.B. Hogervorst, G. Pals, J.T. Wijnen, R.J. van Schooten, C.J. Dommering, G.A. Meijer, M.E. Craanen, P.M. Nederlof, D. de Jong, C.J. McElgunn, J.P. Schouten, and F.H. Menko Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach Br J Cancer 87 2002 892 897
9. K.M. Shannon, P. O'Connell, G.A. Martin, D. Paderanga, K. Olson, P. Dinndorf, and F. McCormick Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders N Engl J Med 330 1994 597 601
10. INK4A codon 94 mutations in a Li-Fraumeni syndrome family Cancer Genet Cytogenet 113 1999 145 151
11. S. Güran, and Y. Tunca Prenatal diagnosis history of a Li-Fraumeni syndrome family [Letter] Cancer Genet Cytogenet 157 2005 191
12. R. Ottman, M.C. Pike, M.C. King, and B.E. Henderson Practical guide for estimating risk for familial breast cancer Lancet 2 8349 1983 556 558
13. D.E. Anderson Genetic study of breast cancer: identification of a high risk group Cancer 34 1974 1090 1097
14. A.S. Perkins, and G.F.V. Waude Principles of molecular cell biology of cancer: oncogenes V.T. De Vita S. Hellman S.A. Rosenberg Cancer: principles and practice of oncology 4th ed. 1993 Lippincott Philadelphia 1264 1332
15. M.C. Southey, M.A. Young, J. Whitty, S. Mifsud, M. Keilar, L. Mead, L. Trute, K. Aittomaki, S.A. McLachlan, H. Debinski, D.J. Venter, and J.E. Armes Molecular pathologic analysis enhances the diagnosis and management of Muir-Torre syndrome and gives insight into it is underlying molecular pathogenesis Am J Surg Pathol 25 2001 936 941
16. F.J. Couch, M.L. DeShano, M.A. Blackwood, K. Calzone, J. Stopfer, L. Campeau, A. Ganguly, T. Rebbeck, and B.L. Weber BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer N Engl J Med 336 1997 1409 1415
17. P. Vahteristo, H. Eerola, A. Tamminen, C. Blomqvist, and H. Nevanlinna A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families Br J Cancer 84 2001 704 708
18. H. Yazici, O. Bitisik, E. Akisik, N. Cabioglu, P. Saip, M. Muslumanoglu, G. Glendon, E. Bengisu, S. Ozbilen, M. Dincer, S. Turkmen, I.L. Andrulis, N. Dalay, and H. Ozcelik BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients Br J Cancer 83 2000 737 742
19. A.E. Manguoǧlu, G. Luleci, T. Özçelik, T. Çolak, H. Schayek, M. Akaydin, and E. Friedman Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patient Hum Mutat 21 2003 444 445
20. H. Yazici, G. Glendon, H. Yazici, S.J. Burnie, P. Saip, F. Buyru, E. Bengisu, I.L. Andrulis, N. Dalay, and H. Ozcelik BRCA1 and BRCA2 mutations in Turkish familial and nonfamilial ovarian cancer patients: a high incidence of mutations in nonfamilial cases Hum Mutat 20 2002 28 34
21. H. Ozdag, M. Tez, I. Sayek, M. Muslumanoǧlu, O. Tarcan, F. Icli, M. Özturk, and T. Özçelik Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients Eur J Cancer 36 2000 2076 2082
22. D. Shattuck-Eidens, A. Oliphant, M. Mc Clure, C. Mc Bride, J. Gupte, T. Rubano, D. Pruss, S.V. Tavtigian, D.H. Teng, N. Adey, M. Staebell, K. Gumpper, R. Lundstrom, M. Hulick, M. Kelly, J. Holmen, B. Lingenfelter, S. Manley, F. Fujimura, M. Luce, B. Ward, L. Cannon-Albright, L. Steele, K. Offit, and A. Thomas BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing JAMA 278 1997 1242 1250
23. S. Güran, M.C. Yenen, M. Dede, A. Özet, and G. Sahin Risk assessment of BRCA1 and BRCA2 gene mutations in hereditary breast cancer cases [In Turkish; abstract in English] Gülhane Tip Dergisi 44 2002 254 259
24. D. Malkin, F.P. Li, L.C. Strong, J.F. Fraumeni Jr., C.E. Nelson, D.H. Kim, J. Kassel, M.A. Gryka, F.Z. Bischoff, and M.A. Tainsky Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms Science 250 1990 1233 1238 [Erratum in: Science1993; 259:878]
25. A.J. Levine, J. Momand, and C.A. Finlay The p53 tumour suppressor gene Nature 351 1991 453 456
26. M. Ponz de Leon, P. Benatti, C. Di Gregorio, M. Pedroni, L. Losi, M. Genuardi, A. Viel, M. Fornasarig, E. Lucci-Cordisco, M. Anti, G. Ponti, F. Borghi, I. Lamberti, and L. Roncucci Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer Br J Cancer 90 2004 882 887
27. A. Umar, C.R. Boland, J.P. Terdiman, S. Syngal, A. de la Chapelle, J. Ruschoff, R. Fishel, N.M. Lindor, L.J. Burgart, R. Hamelin, S.R. Hamilton, R.A. Hiatt, J. Jass, A. Lindblom, H.T. Lynch, P. Peltomaki, S.D. Ramsey, M.A. Rodriguez-Bigas, H.F. Vasen, E.T. Hawk, J.C. Barrett, A.N. Freedman, and S. Srivastava Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability J Natl Cancer Inst 96 2004 261 268